机构

• 上海药物研究所 [17]
• 长春应用化学研究所 [7]
• 合肥物质科学研究院 [5]
• 过程工程研究所 [4]
• 高能物理研究所 [2]
• 金属研究所 [1]
• 更多

采集方式

• OAI收割 [41]
• iSwitch采集 [2]

内容类型

• 期刊论文 [43]

发表日期

• 3111 [1]
• 2026 [1]
• 2025 [2]
• 2024 [2]
• 2023 [1]
• 2022 [2]
• 更多

学科主题

• Materials ... [1]

筛选

浏览/检索结果: 共43条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择发表日期升序发表日期降序题名升序题名降序提交时间升序提交时间降序作者升序作者降序 ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21 (CIP1/WAF1) in human cancer cells1 期刊论文  OAI收割 出版物, 3111, 期号: 0, 页码: 1-35 作者:  Jingru Li;  Yicheng Chen   |  收藏  |  浏览/下载：315/0  |  提交时间：2017/07/24 Abt-263  Sorafenib  Combination Therapy  Cancer   Biomimetic cell membrane-mediated nanodelivery platform based on natural products: Emerging strategies for cancer combination therapy 期刊论文  OAI收割 BIOMATERIALS, 2026, 卷号: 328, 页码: 28 作者:  Jiang, Yingjie;  Hu, Zonglan;  Wei, Yuyu;  Su, Yufei;  Yang, Yanrui   |  收藏  |  浏览/下载：10/0  |  提交时间：2026/01/29 Biomimetic cell membrane  Nanomedicine  Natural product  Drug delivery  Cancer combination therapy   A patent review of CHK1 inhibitors (2019-present) 期刊论文  OAI收割 EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 卷号: 35, 期号: 9, 页码: 915-931 作者:  Liu, Tao;  Su, Mingbo;  Wang, Yuxuan;  Gao, Anhui;  Jiang, Kailong   |  收藏  |  浏览/下载：3/0  |  提交时间：2025/12/04 CHK1  DDR  CHK1 inhibitor  cancer therapy  patent  combination  predictive biomarker   An updated patent review of TEAD modulators (2022-present) 期刊论文  OAI收割 EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 页码: 27 作者:  Xu, Dounan;  Zhong, Jiahuan;  Zeng, Yuhan;  Zhang, Xianhui;  Wang, Chengyu   |  收藏  |  浏览/下载：2/0  |  提交时间：2025/12/04 Hippo signaling pathway  transcriptional enhanced associated domain (TEAD)  modulators  anti-cancer drugs  degraders  combination therapy   Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2024, 卷号: 14 作者:  Gao, Yu   |  收藏  |  浏览/下载：42/0  |  提交时间：2024/11/20 combination therapy  resveratrol  cisplatin  anti-liver cancer mechanism  cell membrane  PLA2   Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 12 作者:  Zou, Zhi-feng;  Yang, Lei;  Nie, Hui-jun;  Gao, Jing;  Lei, Shu-min   |  收藏  |  浏览/下载：55/0  |  提交时间：2024/05/22 proteolysis-targeting chimeras  tumor-targeted delivery  precise protein degradation  combination therapy  triple-negative breast cancer   Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2601-2612 作者:  Wang, Xiaomin;  Xu, Jun;  Sun, Yiming;  Cao, Siyuwei;  Zeng, Hanlin   |  收藏  |  浏览/下载：95/0  |  提交时间：2023/10/17 HDAC inhibitors  Drug resistance  Histone methylation  Histone acetylation  Epigenetic interplay  Hedgehog pathway  ZIC1  LIFR  Combination therapy  Breast cancer   Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 9, 页码: 3726-3738 作者:  Zheng, Chao;  Zhang, Wen;  Wang, Jinming;  Zhai, Yihui;  Xiong, Fengqin   |  收藏  |  浏览/下载：99/0  |  提交时间：2022/12/13 KEY WORDS High-density lipoprotein  Immunotherapy  Combination therapy  Metastasis  Triple-negative breast cancer  Lenvatinib  Vadimezan  Immune checkpoint blockade   Self-assembled Pt(II) metallacycles enable precise cancer combination chemotherapy 期刊论文  OAI收割 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 卷号: 119 作者:  Zhang, Pengge;  Zhou, Zhixuan;  Long, Wen;  Yan, Yuping;  Li, Youshan   |  收藏  |  浏览/下载：74/0  |  提交时间：2022/12/22 self-assembly  supramolecular coordination complex  combination chemotherapy  targeted cancer therapy  drug delivery   If small molecules immunotherapy comes, can the prime be far behind? 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 218 作者:  Zhang, Jingyu;  Zhang, Yu;  Qu, Bingxue;  Yang, Haiyan;  Hu, Shengquan   |  收藏  |  浏览/下载：97/0  |  提交时间：2021/06/15 Cancer immunotherapy  Small molecule inhibitors  Combination therapy  Tumor microenvironment